跳至主要内容
临床试验/PACTR202311592558473
PACTR202311592558473尚未招募3 期

Outcome measures of Tadalafil-Tamsulosin combination therapy versus Tamsulosin alone in the management of benign prostate hyperplasia in patients attending Lagos State University Teaching Hospital.

Atobatele Kazeem0 个研究点目标入组 182 人开始时间: 2023年11月20日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
182

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 Year(s) 至 64 Year(s)(—)
性别
Male

入选标准

  • Patients must be 45 years and above with mild to moderate IPSS (0-19)
  • Patients with PSA less than or equals 4ng/ml, normal DRE and imaging studies
  • Patients with peak flow rate less than 15mls/sec and PVR greater than or equals 50mls
  • Patients who give verbal and written consent to the study

排除标准

  • Patients with severe IPSS, PSA greater than 4ng/ml and peak flow rate greater than 15mls/sec.
  • Patients with PVR less than 50mls.
  • Contraindications to study medications.
  • Patients with no sexual partner during the study period

研究者

发起方
Atobatele Kazeem

相似试验